(Q71838706)

English

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study

scientific article published on 01 July 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

based on heuristic

inferred from title

S J Wimalawansa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 July 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

99

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

36-42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Non-linear bone loss in oophorectomized women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

The risk of hip fracture in postmenopausal females with or without estrogen drug exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

An epidemiologic study of hip fracture in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Bone response to termination of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Prospective trial of oestrogen and calcium in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Diphosphonate Therapy of Paget's Disease of Bone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Diphosphonates and inhibition of bone mineralization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Use of bisphosphonates in the prevention of bone loss and fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Etidronate disodium in the treatment of Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Tetracycline-based histological analysis of bone remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Activities of bone and liver alkaline phosphatases in serum in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Effect of calcium supplementation on bone loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Bone turnover and balance evaluated by a combined calcium balance and 47calcium kinetic study and dynamic histomorphometry

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Histomorphometric analysis of bone in metabolic bone disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Significance of osteoporosis: a growing international health care problem

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

Calcium supplements: Practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980102-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9343(99)80102-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7598140%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71838706&oldid=1940290454"